EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Oesophageal and gastric cancers: From epidemiology to modern treatment

Nikola Milošević, Srđan Milanović

Glasnik javnog zdravlja · 2022

DOI: 10.5937/serbjph2202203m ↗
AbstractBibliografische Angaben

Abstract

Oesophageal and gastric cancers are among the ten most common malignancies in the world. These are diseases of the elderly population, and more common in men. These cancers are multifactorial diseases, with the influence of genetically inherited syndromes and acquired factors such as smoking, obesity, Barrett's oesophagus, and Helicobacter pylori infection. The clinical symptoms include dysphagia, weight loss, mediastinal and abdominal pain, nausea, and malaise. CT examinations of the chest, abdomen, and pelvis, and also esophagogastroduodenoscopy with biopsy and histopathological verification are needed for a complete diagnosis. The most common histological type of oesophageal cancer is squamous cell carcinoma, and most common gastric carcinoma is adenocarcinoma. Screenings for these cancers are not performed routinely, except in countries with a high incidence rate. The most widely accepted TNM classification is used to determine the stage. Oesophageal and gastric cancer treatment is multimodal and includes surgery, chemotherapy, and radiotherapy. Surgery is the first line of treatment in these cancers, especially in the local stages. Chemotherapy is used in almost all stages of the disease. Radiotherapy has its place in treatment, especially in locally advanced stages. It can be used as postoperative and preoperative radiotherapy, usually in combination with chemotherapy. Treatment of oesophageal and gastric cancers in the future will develop in the direction of advancing diagnostics, surgical procedures, immunotherapeutic agents as well as new radiotherapy techniques.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →